AI drug discovery startups are moving beyond software, building their own drug pipelines to attract investors and boost revenue. But as Luka Jelcic notes, blending fast-moving AI with slow-burn biotech isn’t simple. Investors now favor companies with tangible assets over vague platform promises.

Fireside Chat: AI & Drug Development – Challenges, Disruption & the Future.

Inspired by Luka’s co-authored white paper, “Inflection Points of Artificial Intelligence in Drug Development,” this conversation dives deep into trends, challenges, & breakthroughs shaping the future of AI in biopharma.

Wrapping up the #InternationalWomensMonth spotlight with a powerhouse in healthcare innovation: Dr. Elaine Hamm, Executive Director of AAIH. As CEO of Ascend BioVentures, Dr. Hamm champions early-stage life science startups and breakthrough tech. (1 of 2)

In honor of #InternationalWomensMonth, AAIH celebrated Dr. Maria Luisa Pineda, co-founder of Envisagenics & pioneer in AI-driven healthcare innovation. Envisagenics uses AI to detect RNA splicing errors linked to diseases like cancer & ALS, speeding up drug discovery via SpliceCore® platform(1 of 3)

Another amazing woman we celebrated for #InternationalWomensMonth: DeAnn Smith of Foley Hoag LLP! DeAnn leads IP strategy for OCMS Bio, a biotech innovator using AI and on-cell tech to accelerate antibody discovery. Her work protects complex, next-gen methods that outperform traditional approaches.

Celebrating women in AI during #InternationalWomensMonth last month, the AAIH was proud to feature Barbara Fiacco, Co-Chair of IP Litigation at Foley Hoag, who recently spoke at the 10th Annual Naples Roundtable on AI’s growing role in patent law—from claim construction to generative AI in court.

Another incredible woman featured for #InternationalWomensMonth was Helen Zhang from Altis Labs! Helen is innovating oncology trials with AI models that predict long-term drug efficacy using 200M+ images, enabling faster, smarter clinical trials. 1 of 2.

Megan Nacar, AAIH member & DeciBio VP of Commercial, discussed her appointment as a Board Advisor for Helio Genomics, a company leveraging AI & next-generation sequencing to enhance early cancer detection, particularly for hepatocellular carcinoma - a prevalent & deadly form of liver cancer.(2 of 3)

In honor of #InternationalWomensMonth, the AAIH is excited to spotlight the remarkable women who are making significant contributions to the field of AI every day! Today the AAIH is proud to feature Michelle Chen from Insilico Medicine! (1 of 3)

#StudentSpotlight featuring Abraham Obianke, a 4th-year medical student from Ambrose Alli University and member of the AAIH! His research on "Diagnostic accuracy of ECG smart chest patches vs PPG smartwatches for atrial fibrillation detection" was published in BMC Cardiovascular Disorders!

The Alliance for Artificial Intelligence in Healthcare (AAIH) is excited to attend #BIOEuropeSpring in Milan, March 17–19, 2025! Join us to propel the next wave of biotech innovation!

If you are attending, let us know! We would love to meet you!